Clinical Scorecard: MRI Features of Cervical Lymph Nodes with Radioiodine Uptake Identified on Post-Therapeutic ¹³¹I Whole-Body Scintigraphy in Patients with Differentiated Thyroid Carcinoma
At a Glance
Category
Detail
Condition
Differentiated Thyroid Carcinoma
Key Mechanisms
Cervical lymph node metastasis and radioiodine uptake
Target Population
Patients with histologically confirmed differentiated thyroid carcinoma
Care Setting
Oncology and imaging departments
Key Highlights
MRI characteristics of cervical lymph nodes in differentiated thyroid carcinoma were analyzed.
65.5% of radioiodine-avid lymph nodes were round to ovoid in shape.
69.0% of nodes exhibited ill-defined margins.
91.4% of nodes lacked a lymphatic hilum.
MRI can aid in the pre-therapeutic assessment of cervical lymph node metastases.
Guideline-Based Recommendations
Diagnosis
Cervical ultrasonography is the preferred initial imaging modality.
MRI provides superior soft-tissue resolution for assessing lymph node metastases.
Management
Accurate identification of cervical lymph node metastases is essential for optimizing ¹³¹I treatment planning.
Monitoring & Follow-up
Post-therapeutic whole-body scintigraphy is performed to assess iodine-avid lesions.
Risks
False-negative rates in cervical ultrasonography exceed 30%.
